Tumor-infiltrating lymphocytes, particularly the balance between CD8+ T cells and CCR4+ regulatory T cells, affect the survival of patients with oral squamous cell carcinoma

被引:127
作者
Watanabe, Yoshiko
Katou, Fuminori [1 ]
Ohtani, Haruo [2 ]
Nakayama, Takashi [3 ]
Yoshie, Osamu [3 ]
Hashimoto, Kenji
机构
[1] Hamamatsu Univ Sch Med, Dept Oral & Maxillofacial Surg, Higashi Ku, Hamamatsu, Shizuoka 4313125, Japan
[2] Mito Med Ctr, Dept Pathol, Ibaraki, Japan
[3] Kinki Univ, Dept Microbiol, Osaka, Japan
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY | 2010年 / 109卷 / 05期
关键词
PROGNOSTIC-FACTOR; OVARIAN-CANCER; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; CERVICAL-CANCER; POOR SURVIVAL; EFFECTOR; RECRUITMENT; IMMUNOSURVEILLANCE; SUPPRESSION;
D O I
10.1016/j.tripleo.2009.12.015
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective. The objective of this study was to clarify the prognostic significance of tumor-infiltrating lymphocytes (TILs) in oral squamous cell carcinoma (OSCC); the present study analyzed various TIL-related parameters. Study design. Immunohistochemistry was performed in 87 patients with OSCC for the following TIL-related parameters: nest-CD8(+) T cells, stromal CD8(+) T cells, CD4(+) T cells, total regulatory T cells (Tregs), CCR4(+) Tregs, ratio of nest CD8(+) T cells/CCR4(+) Tregs, and ratio of stromal CD8(+) T cells/CCR4(+) Tregs. Results. In univariate analyses, the following parameters were associated with decreased survival: few nest-and stromal CD8(+) T cells and more stromal CCR4(+) Tregs, but not total Tregs. Low ratios of nest and stromal CD8(+) T cell/CCR4(+) Treg were associated with worse survival. In multivariate analysis, the stromal CD8(+) T cell/CCR4(+) Treg ratio was an independent prognostic factor. Conclusion. Host immune responses in the stroma of OSCC affect the survival of the patients. The in situ balance between effector T cells and regulatory T cells is the most important factor predicting survival. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 744-752)
引用
收藏
页码:744 / 752
页数:9
相关论文
共 36 条
  • [1] [Anonymous], 2005, World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours
  • [2] Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL
    Baatar, Dolgor
    Olkhanud, Purevdorj
    Sumitomo, Kenya
    Taub, Dennis
    Gress, Ronald
    Biragyn, Arya
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (08) : 4891 - 4900
  • [3] Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
    Bates, Gaynor J.
    Fox, Stephen B.
    Han, Cheng
    Leek, Russell D.
    Garcia, Jose F.
    Harris, Adrian L.
    Banham, Alison H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) : 5373 - 5380
  • [4] Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins
    Bui, Jack D.
    Uppaluri, Ravindra
    Hsieh, Chyi-Song
    Schreiber, Robert D.
    [J]. CANCER RESEARCH, 2006, 66 (14) : 7301 - 7309
  • [5] Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma:: possible association with suppression of micrometastasis
    Chiba, T
    Ohtani, H
    Mizoi, T
    Naito, Y
    Sato, E
    Nagura, H
    Ohuchi, A
    Ohuchi, K
    Shiiba, K
    Kurokawa, Y
    Satomi, S
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (09) : 1711 - 1717
  • [6] Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells
    Clark, Rachael A.
    Huang, Susan J.
    Murphy, George F.
    Mollet, Ilse G.
    Hijnen, Dirkjan
    Muthukuru, Manoj
    Schanbacher, Carl F.
    Edwards, Vonetta
    Miller, Danielle M.
    Kim, Jenny E.
    Lambert, Jo
    Kupper, Thomas S.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (10) : 2221 - 2234
  • [7] Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
    Curiel, TJ
    Coukos, G
    Zou, LH
    Alvarez, X
    Cheng, P
    Mottram, P
    Evdemon-Hogan, M
    Conejo-Garcia, JR
    Zhang, L
    Burow, M
    Zhu, Y
    Wei, S
    Kryczek, I
    Daniel, B
    Gordon, A
    Myers, L
    Lackner, A
    Disis, ML
    Knutson, KL
    Chen, LP
    Zou, WP
    [J]. NATURE MEDICINE, 2004, 10 (09) : 942 - 949
  • [8] Regulatory T cells and treatment of cancer
    Curiel, Tyler J.
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (02) : 241 - 246
  • [9] The immunobiology of cancer immunosurveillance and immunoediting
    Dunn, GP
    Old, LJ
    Schreiber, RD
    [J]. IMMUNITY, 2004, 21 (02) : 137 - 148
  • [10] Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
    Fu, Junliang
    Xu, Dongping
    Liu, Zhenwen
    Shi, Ming
    Zhao, Ping
    Fu, Baoyun
    Zhang, Zheng
    Yang, Huiyin
    Zhang, Hui
    Zhou, Chunbao
    Ya, Jinxia
    Jin, Lei
    Wang, Huifen
    Yang, Yongping
    Fu, Yang-Xing
    Wang, Fu-Sheng
    [J]. GASTROENTEROLOGY, 2007, 132 (07) : 2328 - 2339